A Comparative Analysis of Models Used to Evaluate the Cost-Effectiveness of Dabigatran Versus Warfarin for the Prevention of Stroke in Atrial Fibrillation

por Sorensen, Sonja V., Peng, Siyang, Monz, Brigitta U., Bradley-Kennedy, Carole, Kansal, Anuraag R.
Publicado 2013

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation

por Kansal, Anuraag R, Sorensen, Sonja V, Gani, Ray, Robinson, Paul, Pan, Feng, Plumb, Jonathan M, Cowie, Martin R
Publicado 2012